To investigate whether Sp1 and PU.1 were involved in the palmitic acid-increased TLR4 expressions, we separately knockdown Sp1 and PU.1 in the CRC cells before palmitic acid treatments. The gene discussed is SP1; the disease is colorectal carcinoma.